Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In re: Flonase Antitrust Litig
Case Number:
16-1124
Court:
Nature of Suit:
Companies
- American Tort Reform Association
- International Brotherhood of Electrical Workers
- National Association of Manufacturers
- Washington Legal Foundation
Sectors & Industries:
-
February 07, 2018
3rd Circ. Denies GSK Rehearing Bid In Flonase Antitrust Suit
The Third Circuit on Wednesday said it won't reconsider its decision to let Louisiana sue GlaxoSmithKline for allegedly blocking a generic version of its nasal spray Flonase despite the state not actively opting out of a 2013 class action settlement.
-
January 17, 2018
Chamber Backs GSK In 3rd Circ. Flonase Rehearing Bid
Letting Louisiana bring claims that GlaxoSmithKline PLC blocked generic versions of its Flonase nasal spray, after the state was involved in a class settlement over the same allegations, would "deal a major blow" to such deals, the U.S. Chamber of Commerce told the Third Circuit on Tuesday.
-
January 08, 2018
GSK Wants 3rd Circ. To Rehear La. Flonase Decision
GlaxoSmithKline PLC on Friday asked the Third Circuit to reconsider a decision that found the state of Louisiana was not barred by a class action antitrust settlement from bringing its own claims over allegations that the company stymied generic competition for its Flonase nasal spray.
-
December 22, 2017
La. Not Bound By Flonase Antitrust Settlement: 3rd Circ.
The Third Circuit issued a published decision on Friday finding that a class action antitrust settlement GlaxoSmithKline inked over alleged efforts to stymie generic competition for Flonase nasal spray did not bar the state of Louisiana from pursuing its own claims over the drug.